Immatics (IMTX) Cash & Equivalents (2019 - 2025)

Immatics (IMTX) reported Cash & Equivalents of $402.7 million for Q4 2025, up 59.16% on a YoY basis from $253.0 million in Q4 2024, and up 2.84% sequentially from $391.5 million in Q3 2025.

Immatics (IMTX) Cash & Equivalents (2019 - 2025) Analysis & Trends

Immatics (IMTX) has 7 years of Cash & Equivalents data on file, last reported at $402.7 million in Q4 2025.

  • For the quarter ending Q4 2025, Cash & Equivalents rose 59.16% year-over-year to $402.7 million; the trailing twelve-month figure through Dec 2025 stood at $402.7 million (up 59.16% YoY), and the FY2025 full-year result was $390.8 million, up 52.52% from the prior year.
  • Cash & Equivalents advanced to $402.7 million in Q4 2025, from $391.5 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $402.7 million in Q4 2025 to a low of $90.8 million in Q3 2023.
  • A 5-year average of $219.0 million and a median of $200.3 million in 2021 frame the typical range for Cash & Equivalents.
  • Across the five-year window, Cash & Equivalents sank 54.4% in 2023 and surged 128.74% in 2024, its largest moves.
  • Tracing IMTX's Cash & Equivalents over 5 years: stood at $152.1 million in 2021, then declined by 0.4% to $151.5 million in 2022, then surged by 55.13% to $235.1 million in 2023, then climbed by 7.63% to $253.0 million in 2024, then surged by 59.16% to $402.7 million in 2025.
  • Business Quant data shows IMTX's Cash & Equivalents at $402.7 million in Q4 2025, $391.5 million in Q3 2025, and $290.5 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 82.45 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 61.40 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 4.79 Bn
4 NuCana 279.75 Bn 279.75 Bn - 32.26 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 5.49 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 2.96 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 3.58 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 440.94 Mn
10 Immatics 1.14 Bn 1.14 Bn - 402.66 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 402.66 Mn
Sep 30, 2025 391.54 Mn
Jun 30, 2025 290.50 Mn
Mar 31, 2025 255.44 Mn
Dec 31, 2024 252.99 Mn
Sep 30, 2024 207.78 Mn
Jun 30, 2024 170.30 Mn
Mar 31, 2024 132.64 Mn
Dec 31, 2023 235.06 Mn
Sep 30, 2023 90.84 Mn
Jun 30, 2023 161.73 Mn
Mar 31, 2023 126.57 Mn
Dec 31, 2022 151.53 Mn
Sep 30, 2022 179.52 Mn
Jun 30, 2022 282.90 Mn
Mar 31, 2022 277.57 Mn
Dec 31, 2021 152.14 Mn
Sep 30, 2021 190.21 Mn
Jun 30, 2021 192.80 Mn
Mar 31, 2021 235.62 Mn